GE HealthCare Technologies Past Earnings Performance
Past criteria checks 1/6
GE HealthCare Technologies's earnings have been declining at an average annual rate of -5.5%, while the Medical Equipment industry saw earnings growing at 11.1% annually. Revenues have been growing at an average rate of 4.2% per year. GE HealthCare Technologies's return on equity is 21.4%, and it has net margins of 8.1%.
Key information
-5.5%
Earnings growth rate
-7.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 4.2% |
| Return on equity | 21.4% |
| Net Margin | 8.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)
May 02GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price
Apr 25
GE Vernova: An Interesting Stalwart To Ride The Energy Transition
Apr 02GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive
Mar 25GE HealthCare Technologies' Roar Higher Isn't Over Yet
Mar 09GE HealthCare Technologies: Stable Business, But Future Upside Seems Limited
Feb 14GE HealthCare Q4 Earnings: Growth Lagging The Market
Feb 06Why GE HealthCare May Be Up To 50% Undervalued
Jan 11GE HealthCare Technologies (NASDAQ:GEHC) May Have Issues Allocating Its Capital
Jan 05GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Could Be 29% Above Their Intrinsic Value Estimate
Oct 23GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 44% Above Its Share Price
Jun 28Some Confidence Is Lacking In GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) P/E
Apr 17Revenue & Expenses BreakdownBeta
How GE HealthCare Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 19,495 | 1,574 | 3,755 | 1,259 |
| 31 Dec 23 | 19,552 | 1,389 | 3,767 | 1,205 |
| 30 Sep 23 | 19,284 | 1,534 | 3,676 | 1,161 |
| 30 Jun 23 | 19,038 | 1,643 | 3,703 | 1,099 |
| 31 Mar 23 | 18,705 | 1,698 | 3,637 | 1,058 |
| 31 Dec 22 | 18,341 | 1,898 | 3,621 | 1,026 |
| 30 Sep 22 | 17,992 | 1,914 | 3,652 | 980 |
| 30 Jun 22 | 17,720 | 1,929 | 3,660 | 920 |
| 31 Mar 22 | 17,582 | 2,037 | 3,624 | 859 |
| 31 Dec 21 | 17,585 | 2,229 | 3,564 | 816 |
| 31 Dec 20 | 17,164 | 2,007 | 3,241 | 810 |
| 31 Dec 19 | 16,633 | 1,652 | 3,599 | 833 |
Quality Earnings: GEHC has high quality earnings.
Growing Profit Margin: GEHC's current net profit margins (8.1%) are lower than last year (9.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GEHC's earnings have declined by 5.5% per year over the past 5 years.
Accelerating Growth: GEHC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: GEHC had negative earnings growth (-7.3%) over the past year, making it difficult to compare to the Medical Equipment industry average (2.6%).
Return on Equity
High ROE: Whilst GEHC's Return on Equity (21.36%) is high, this metric is skewed due to their high level of debt.